Corcept Therapeutics, Inc. (CORT)
34.80
-35.40
(-50.42%)
USD |
NASDAQ |
Dec 31, 16:00
34.80
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Free Cash Flow: 162.57M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 20.46B |
| United Therapeutics Corp. | 1.116B |
| Amgen, Inc. | 11.54B |
| Vertex Pharmaceuticals, Inc. | 3.337B |
| Theravance Biopharma, Inc. | 243.48M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 54.48M |
| Cash from Investing (Quarterly) | 14.64M |
| Cash from Financing (Quarterly) | -46.41M |
| Free Cash Flow Per Share (Quarterly) | 0.4561 |
| Free Cash Flow to Equity (Quarterly) | 54.73M |
| Free Cash Flow to Firm (Quarterly) | 54.48M |
| Free Cash Flow Yield | 3.91% |